WO2024135881A1 - Information provision method for diagnosing etiology of psychogenic non-epileptic seizures - Google Patents
Information provision method for diagnosing etiology of psychogenic non-epileptic seizures Download PDFInfo
- Publication number
- WO2024135881A1 WO2024135881A1 PCT/KR2022/020952 KR2022020952W WO2024135881A1 WO 2024135881 A1 WO2024135881 A1 WO 2024135881A1 KR 2022020952 W KR2022020952 W KR 2022020952W WO 2024135881 A1 WO2024135881 A1 WO 2024135881A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pnes
- epileptic seizures
- etiology
- patients
- psychogenic
- Prior art date
Links
- 208000037321 Psychogenic Nonepileptic Seizures Diseases 0.000 title claims abstract description 61
- 238000000034 method Methods 0.000 title claims abstract description 12
- 208000014674 injury Diseases 0.000 claims abstract description 12
- 230000008733 trauma Effects 0.000 claims abstract description 12
- 201000003723 learning disability Diseases 0.000 claims abstract description 10
- 230000001568 sexual effect Effects 0.000 claims description 13
- 238000003745 diagnosis Methods 0.000 claims description 7
- 208000024891 symptom Diseases 0.000 description 15
- 206010010904 Convulsion Diseases 0.000 description 13
- 206010015037 epilepsy Diseases 0.000 description 12
- 230000004064 dysfunction Effects 0.000 description 6
- 238000011269 treatment regimen Methods 0.000 description 5
- 230000002996 emotional effect Effects 0.000 description 4
- 230000001037 epileptic effect Effects 0.000 description 3
- 230000004630 mental health Effects 0.000 description 3
- 208000020016 psychiatric disease Diseases 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 208000037490 Medically Unexplained Symptoms Diseases 0.000 description 2
- 206010042464 Suicide attempt Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000002650 habitual effect Effects 0.000 description 2
- 230000002109 interictal effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 238000007473 univariate analysis Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 208000027448 Attention Deficit and Disruptive Behavior disease Diseases 0.000 description 1
- 208000027691 Conduct disease Diseases 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 238000000729 Fisher's exact test Methods 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 238000000585 Mann–Whitney U test Methods 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 208000037919 acquired disease Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000009225 cognitive behavioral therapy Methods 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001787 epileptiform Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 208000024196 oppositional defiant disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009430 psychological distress Effects 0.000 description 1
- 230000008255 psychological mechanism Effects 0.000 description 1
- 238000013102 re-test Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Definitions
- the present invention relates to a method of providing information that takes age and gender differences into account in diagnosing the etiology of psychogenic non-epileptic seizures, and can be utilized in the medical field.
- PNES Psychogenic non-epileptic seizures
- Psychogenic non-epileptic seizures are seizures that are similar to epileptic seizures, but do not show the electrical discharges seen in epileptic seizures.
- Psychogenic non-epileptic seizures belong to the category of functional neurological disorders and are recently called functional seizures.
- Psychogenic non-epileptic seizures are a sign of psychological distress.
- PNES is an acquired disorder in which patients may dissociate in response to previous trauma or severe stress.
- Psychogenic non-epileptic seizures occur disproportionately in women, and the female-to-male ratio is consistently reported to be approximately 3:1. Gender differentiation is reported to become apparent after puberty, usually before the age of 55.
- Psychogenic non-epileptic seizures begin to increase from puberty and most commonly occur in late adolescence and young adulthood in women. In contrast, men develop PNES at approximately the same rate over their lifetime.
- the purpose of the present invention is to provide a method of providing information for diagnosing the etiology of pediatric patients with psychogenic non-epileptic seizures.
- the present invention reveals significant differences in psychogenic non-epileptic seizures according to age and gender and provides effective information for diagnosing the etiology of pediatric psychogenic non-epileptic seizure patients. Furthermore, this can be used as a reference in establishing treatment strategies according to the etiology.
- Figure 1 is a graphical representation of the Pediatric Symptom Checklist-17 results.
- Figure 2 is a graph showing the results of the Pediatric Physical Symptom Test-8. Responses were scored using a 4-point scale from 1 (not at all) to 4 (very much), with bothersome symptoms defined as a single item scored 3 or higher.
- the present invention provides information that, if the pediatric psychogenic non-epileptic seizure is a girl, there is a higher probability that it is due to trauma than if the patient is a boy, and if the patient is a boy, there is a higher probability that it is due to a learning disability than if the patient is a girl; It relates to a method of providing information for diagnosing the etiology of pediatric patients with psychogenic non-epileptic seizures, including:
- Seizures refer to temporary seizure changes that occur unexpectedly due to abnormal neural activity, and can be classified into epileptic and non-epileptic.
- the above-mentioned psychogenic non-epileptic seizures refer to non-epileptic seizures caused by psychological factors, such as moving the head left and right, impaired consciousness, asynchronous movement of limbs, closed eyes, abnormal muscle tension, etc. There may be symptoms.
- psychogenic non-epileptic seizures are related to psychological mechanisms, such as family dysfunction, school problems, sexual abuse, physical abuse, emotional abuse, witnessing and experiencing violence, sudden death of a loved one, serious accident or illness, refugees, and war.
- the etiology, including experience, is diverse.
- the present invention can provide information according to gender differences in diagnosing the etiology of pediatric psychogenic non-epileptic seizure patients.
- the children may include, for example, those over 4, 7, or 8 years of age, and those under 15, 17, 18, or 19 years of age.
- the present invention analyzed the factors of psychogenic non-epileptic seizures in children based on gender differences and confirmed that trauma and learning disabilities can be significant variables.
- the probability of psychogenic non-epileptic seizures caused by trauma, specifically sexual abuse is higher than that of boys, which can be used to establish diagnosis or treatment strategies.
- the above-mentioned trauma refers to the symptom of experiencing psychological anxiety by reliving the emotions of the time when something similar to a crisis or fear experienced in the past occurs.
- the above sexual abuse refers to forced or illegal sexual abuse and damage that occurs against or against the will of the other person for one's own sexual satisfaction, and includes sexual violence or harsh acts such as sexual harassment, sexual harassment, and sexual assault. do.
- the probability of psychogenic non-epileptic seizures due to learning disabilities is higher than that of girls, which can be used to establish diagnosis or treatment strategies.
- the above-mentioned learning disabilities refer to a variety of disabilities that present specific difficulties in the acquisition or use of listening, speaking, reading, writing, reasoning, and arithmetic skills. This may be caused by factors such as genetic predisposition, acquired brain damage, biochemical factors, environmental malnutrition, and nutrition. Learning disabilities are inherent in the individual and are presumed to be caused by damage to the central nervous system.
- the present invention provides information that the probability of suicidal thoughts or suicide attempts in female psychogenic non-epileptic seizure patients is significantly higher than in male psychogenic non-epileptic seizure patients.
- the above information can be used, for example, to establish a treatment strategy that intervenes more actively in preventing suicidal thoughts or suicide attempts in female patients with psychogenic non-epileptic seizures than in boys, but is not limited to this.
- Demographics age, gender, race
- Clinical variables included age at onset of PNES, frequency of seizures, frequency of emergency department visits in the past year, history of psychiatric diagnosis and medication, severe suicidal thoughts or attempts, concurrent epilepsy or history of epilepsy, learning disability, family history of seizures or mental disorders, and social environment (family). dysfunction and school problems) and history of trauma (sexual and non-sexual abuse).
- Non-sexual abuse includes physical abuse, emotional abuse, and witnessing or experiencing violence in the family or home.
- Family dysfunction included divorce or separation, single parenthood, and severe family conflict.
- Psychosocial functioning and somatic symptoms were also routinely assessed using the Pediatric Symptom Checklist-17 (PSC-17) and Pediatric Somatic Symptom Inventory-8 (CSSI-8).
- the PSC-17 is a 17-item questionnaire developed from measures completed by parents to assess psychosocial problems in pediatric patients aged 4 to 18 years.
- Four scores can be derived from the completed PSC-17: total score, externalizing subscale score, internalizing subscale score, and attention subscale score.
- the total score ranges from 0 to 34 and is designed to assess the child's overall psychosocial functioning. The higher the score, the greater the risk.
- a validated cutoff score of _15 on the total score indicates overall mental health risk.
- a score of _7 indicates risk for both the Attention and Externalizing subscales and a score of _5 indicates risk for the Internalizing subscale.
- Positive scores are associated with the risk of certain underlying mental health problems.
- the CSSI-8 is an 8-item questionnaire to assess physical symptoms over the past 2 weeks in children and adolescents aged 8 to 17 years. These items were derived from the validated 24-item Children's Somatization Test and were used when a simple measurement was needed. Addressed abdominal pain, head, back, arms/legs, fainting/dizziness, fast heartbeat, nausea/stomach issues and weakness. Each item was scored from 1 (not concerned) to 4 (very concerned), and the average score was calculated. Troublesome symptoms were defined as a single item with a score of 3 or higher. Cronbach's alpha was acceptable in the range of 0.75-0.77 in previous studies. All procedures were approved by the CHOA Institutional Review Board (IRB).
- IRS Institutional Review Board
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Physics & Mathematics (AREA)
- Data Mining & Analysis (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The present invention provides a novel method of providing information according to gender when diagnosing the etiology of psychogenic non-epileptic seizures in children, upon confirming that trauma and learning disability are significant variables in the etiology of psychogenic non-epileptic seizures depending on age and gender.
Description
본 발명은 심인성비뇌전증발작의 병인 진단에서 연령 및 성별 차이를 고려한 정보제공방법에 관한 것으로 의료 분야에서 활용될 수 있다.The present invention relates to a method of providing information that takes age and gender differences into account in diagnosing the etiology of psychogenic non-epileptic seizures, and can be utilized in the medical field.
심인성비뇌전증발작(PNES)은 뇌전증 발작과 유사한 발작이지만, 뇌전증성 발작에서 보이는 전기적 방전을 보이지 않는다. 심인성비뇌전증발작은 기능적 신경 장애의 범주에 속하며 최근에는 기능적 발작이라고 하다. 심인성비뇌전증발작은 심리적 고통의 징후이다. 즉, PNES는 환자가 이전의 외상이나 심각한 스트레스에 대한 반응으로 해리될 수 있는 후천성 장애이다. 심인성비뇌전증발작은 여성에게 과도하게 나타나며 여성 대 남성 비율은 일관되게 약 3:1로 보고되고 있다. 성별 구분은 사춘기 이후, 일반적으로 55세 이전에 분명해지는 것으로 보고되었다. 심인성비뇌전증발작은 사춘기부터 증가하기 시작하여, 여성에서 청소년기 후반에서 청년기에 가장 흔히 발현된다. 이와는 대조적으로, 남성은 평생에 걸쳐 PNES가 발생하는 비율이 거의 동일하다.Psychogenic non-epileptic seizures (PNES) are seizures that are similar to epileptic seizures, but do not show the electrical discharges seen in epileptic seizures. Psychogenic non-epileptic seizures belong to the category of functional neurological disorders and are recently called functional seizures. Psychogenic non-epileptic seizures are a sign of psychological distress. In other words, PNES is an acquired disorder in which patients may dissociate in response to previous trauma or severe stress. Psychogenic non-epileptic seizures occur disproportionately in women, and the female-to-male ratio is consistently reported to be approximately 3:1. Gender differentiation is reported to become apparent after puberty, usually before the age of 55. Psychogenic non-epileptic seizures begin to increase from puberty and most commonly occur in late adolescence and young adulthood in women. In contrast, men develop PNES at approximately the same rate over their lifetime.
여성에게 PNES가 우세하게 나타나는 이유는 완전히 설명되고 있지 않지만, 이러한 결과는 특히 여성의 PNES 병인에서, 연령과 성별이 상호 작용하는 점을 시사하고, 성별이 PNES에 미치는 영향을 이해하려면 모든 연령의 데이터가 필요하다. 특히 사춘기 동안의 성별 차이는 치료에 중요한 영향을 미칠 수 있다. 그러나 현재 PNES가 있는 소아 인구의 성별 차이를 조사한 연구는 단 한 건 뿐으로, 이 연구는 아동기 발병 소아 PNES에서 임상 인구 통계 및 심리 사회적 기능의 성별 관련 차이를 조사하고 있다(Say GN, Tasdemir HA, Ince H. Semiological and psychiatric characteristics of children with psychogenic nonepileptic seizures: Gender-related differences. Seizure 2015;31:144-8.).Although the predominance of PNES in women is not fully explained, these results suggest an interaction between age and gender, particularly in the etiology of PNES in women, and data at all ages are needed to understand how gender affects PNES. is needed. Gender differences, especially during puberty, may have important implications for treatment. However, there is currently only one study examining gender differences in the pediatric population with PNES, and this study is examining gender-related differences in clinical demographics and psychosocial functioning in childhood-onset pediatric PNES (Say GN, Tasdemir HA, Ince H. Semiological and psychiatric characteristics of children with psychogenic nonepileptic seizures: Gender-related differences.)
본 발명의 목적은 소아 심인성비뇌전증발작 환자의 병인 진단을 위한 정보제공방법을 제공함에 있다.The purpose of the present invention is to provide a method of providing information for diagnosing the etiology of pediatric patients with psychogenic non-epileptic seizures.
1. 소아 심인성비뇌전증발작 환자가 여아인 경우 남아인 경우보다 트라우마로 인한 것일 확률이 높을 것이며, 남아인 경우 여아인 경우보다 학습장애로 인한 것일 확률이 높을 것이라는 정보를 제공하는 단계;를 포함하는, 소아 심인성비뇌전증발작 환자의 병인 진단을 위한 정보제공방법.1. Providing information that if the pediatric psychogenic non-epileptic seizure is a girl, there is a higher probability that it is due to trauma than if the patient is a boy, and if the patient is a boy, the probability that it is caused by a learning disability is higher than if the patient is a girl; including; A method of providing information for diagnosing the etiology of patients with psychogenic non-epileptic seizures in children.
2. 청구항 1에 있어서, 상기 트라우마는 성적 학대로 인한 것인 소아 심인성비뇌전증발작 환자의 병인 진단을 위한 정보제공방법.2. The method of claim 1, wherein the trauma is due to sexual abuse.
본 발명은 심인성비뇌전증발작에 있어 연령 및 성별에 따른 유의한 차이를 밝혀 소아 심인성비뇌전증발작 환자의 병인 진단에 효과적인 정보를 제공한다. 나아가 이는 병인에 따른 치료 전략 수립에 참고될 수 있다.The present invention reveals significant differences in psychogenic non-epileptic seizures according to age and gender and provides effective information for diagnosing the etiology of pediatric psychogenic non-epileptic seizure patients. Furthermore, this can be used as a reference in establishing treatment strategies according to the etiology.
도 1은 소아 증상 체크리스트-17 결과를 그래프로 나타낸 것이다.Figure 1 is a graphical representation of the Pediatric Symptom Checklist-17 results.
도 2는 소아의 신체증상검사-8 결과를 그래프로 나타낸 것이다. 응답은 1(전혀 아님)에서 4(매우 많이)까지의 4점 척도를 사용하여 채점되었으며, 성가신 증상은 3점 이상의 단일 항목으로 정의되었다.Figure 2 is a graph showing the results of the Pediatric Physical Symptom Test-8. Responses were scored using a 4-point scale from 1 (not at all) to 4 (very much), with bothersome symptoms defined as a single item scored 3 or higher.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 소아 심인성비뇌전증발작 환자가 여아인 경우 남아인 경우보다 트라우마로 인한 것일 확률이 높을 것이며, 남아인 경우 여아인 경우보다 학습장애로 인한 것일 확률이 높을 것이라는 정보를 제공하는 단계;를 포함하는, 소아 심인성비뇌전증발작 환자의 병인 진단을 위한 정보제공방법에 관한 것이다.The present invention provides information that, if the pediatric psychogenic non-epileptic seizure is a girl, there is a higher probability that it is due to trauma than if the patient is a boy, and if the patient is a boy, there is a higher probability that it is due to a learning disability than if the patient is a girl; It relates to a method of providing information for diagnosing the etiology of pediatric patients with psychogenic non-epileptic seizures, including:
발작은 비정상적인 신경 활동으로 인해 예기치 않게 발생하는 일시적 발작 변화를 의미하며, 뇌전증성과 비뇌전증성으로 분류할 수 있다.Seizures refer to temporary seizure changes that occur unexpectedly due to abnormal neural activity, and can be classified into epileptic and non-epileptic.
상기 심인성비뇌전증발작은 심리적 요인으로 인한 비뇌전증성 발작을 의미하며, 머리를 좌우고 움직이거나, 의식 장애가 생기거나, 비동시적으로 사지가 움직이거나, 눈이 감기거나, 근육 긴장 이상 자세를 보이는 등의 증상이 있을 수 있다.The above-mentioned psychogenic non-epileptic seizures refer to non-epileptic seizures caused by psychological factors, such as moving the head left and right, impaired consciousness, asynchronous movement of limbs, closed eyes, abnormal muscle tension, etc. There may be symptoms.
즉, 심인성비뇌전증발작은 심리적 기제와 관련된 것으로, 가족 기능 장애, 학교 문제, 성적 학대, 신체적 학대, 정서적 학대, 폭력의 목격과 경험, 사랑하는 사람의 갑작스러운 죽음, 심각한 사고 또는 질병, 난민 및 전쟁 경험 등 병인이 다양하다.In other words, psychogenic non-epileptic seizures are related to psychological mechanisms, such as family dysfunction, school problems, sexual abuse, physical abuse, emotional abuse, witnessing and experiencing violence, sudden death of a loved one, serious accident or illness, refugees, and war. The etiology, including experience, is diverse.
본 발명에서는 상기 소아 심인성비뇌전증발작 환자의 병인을 진단하는 데 있어 성별 차이에 따른 정보를 제공할 수 있다. The present invention can provide information according to gender differences in diagnosing the etiology of pediatric psychogenic non-epileptic seizure patients.
상기 소아는 예를 들면 4세, 7세 또는 8세 이상, 그리고 15세, 17세, 18세 또는 19세 이하의 연령을 포함하는 것일 수 있다.The children may include, for example, those over 4, 7, or 8 years of age, and those under 15, 17, 18, or 19 years of age.
구체적으로, 본 발명에서는 성별에 따른 차이를 기초로 소아 심인성비뇌전증발작의 요인을 분석하여, 트라우마 및 학습장애가 유의한 변수가 될 수 있음을 확인하였다.Specifically, the present invention analyzed the factors of psychogenic non-epileptic seizures in children based on gender differences and confirmed that trauma and learning disabilities can be significant variables.
이는 심인성비뇌전증발작의 병인 진단에 대한 정보를 제공할 수 있고, 나아가 진단된 병인을 바탕으로 적절한 치료 전략을 수립하는 데 활용될 수 있다.This can provide information on the diagnosis of the etiology of psychogenic non-epileptic seizures and can further be used to establish an appropriate treatment strategy based on the diagnosed etiology.
예를 들면 여아의 경우, 트라우마, 구체적으로 성적 학대에 기인한 심인성비뇌전증발작일 확률이 남아의 경우보다 높은 관점에서 진단 또는 치료 전략을 수립하는 데 활용될 수 있다.For example, in the case of girls, the probability of psychogenic non-epileptic seizures caused by trauma, specifically sexual abuse, is higher than that of boys, which can be used to establish diagnosis or treatment strategies.
상기 트라우마는 과거 경험했던 위기나 공포와 비슷한 일이 발생했을 때, 당시의 감정을 다시 느끼면서 심리적 불안을 겪는 증상을 의미한다.The above-mentioned trauma refers to the symptom of experiencing psychological anxiety by reliving the emotions of the time when something similar to a crisis or fear experienced in the past occurs.
상기 성적(sexual) 학대는 자신의 성적 만족을 위해서 상대방의 뜻에 반하거나 혹은 의사를 무시하고 일어나는 강제적 혹은 비합법적 성 관련 학대 및 피해를 의미하며, 성희롱, 성추행, 성폭행 등 성적 폭력이나 가혹행위를 포함한다.The above sexual abuse refers to forced or illegal sexual abuse and damage that occurs against or against the will of the other person for one's own sexual satisfaction, and includes sexual violence or harsh acts such as sexual harassment, sexual harassment, and sexual assault. do.
예를 들면 남아의 경우, 학습장애에 기인한 심인성비뇌전증발작일 확률이 여아의 경우보다 높은 관점에서 진단 또는 치료 전략을 수립하는 데 활용될 수 있다.For example, in the case of boys, the probability of psychogenic non-epileptic seizures due to learning disabilities is higher than that of girls, which can be used to establish diagnosis or treatment strategies.
상기 학습장애는 듣기, 말하기, 읽기, 쓰기, 추리, 산술의 습득이나 사용에 있어 특정한 어려움을 보이는 여러 가지 장애를 의미한다. 이는 유전적 소인, 후천적 뇌손상, 생화학적 요인, 환경실조와 영양 등의 원인으로 발생하는 것일 수 있다. 학습장애는 개인에게 내재하는 것으로 중추신경계 손상에 의한 것으로 추정되고 있다.The above-mentioned learning disabilities refer to a variety of disabilities that present specific difficulties in the acquisition or use of listening, speaking, reading, writing, reasoning, and arithmetic skills. This may be caused by factors such as genetic predisposition, acquired brain damage, biochemical factors, environmental malnutrition, and nutrition. Learning disabilities are inherent in the individual and are presumed to be caused by damage to the central nervous system.
또한, 본 발명에서는 여아 심인성비뇌전증발작 환자의 경우 자살 충동 또는 자살 시도 확률이 남아 심인성비뇌전증발작 환자보다 유의하게 높다는 정보를 제공한다.In addition, the present invention provides information that the probability of suicidal thoughts or suicide attempts in female psychogenic non-epileptic seizure patients is significantly higher than in male psychogenic non-epileptic seizure patients.
상기 정보는 예를 들면, 이를 제공하여 여아 심인성비뇌전증발작 환자의 자살 충동 또는 자살 시도 예방에 남아의 경우보다 적극적으로 개입하는 치료 전략을 수립하는 데 활용될 수 있으나, 이에 제한되는 것은 아니다.The above information can be used, for example, to establish a treatment strategy that intervenes more actively in preventing suicidal thoughts or suicide attempts in female patients with psychogenic non-epileptic seizures than in boys, but is not limited to this.
이하, 본 발명을 구체적으로 설명하기 위해 실시예를 들어 상세하게 설명하기로 한다. Hereinafter, the present invention will be described in detail with reference to examples.
실시예Example
1. 환자군 및 실험 방법1. Patient group and experimental method
2019년 7월부터 2020년 3월까지 애틀랜타 아동 건강 관리(CHOA)의 PNES 클리닉에서 평가된 연속 환자의 의료 차트를 후향적으로 검토했다. PNES 클리닉은 Emory University CHOA 소아과 소아 신경과 내에 있다. CHOA의 PNES 클리닉은 PNES 환자를 평가에서 치료로 전환하는 데 중점을 둔다. 전형적인 의뢰 과정(referral source)에는 신경과 전문의, 응급 의료 종사자, EEG 모니터링 장치를 포함한 병원 내 상담 및 1차 진료 제공자가 포함되었다. 클리닉 팀은 소아 뇌전증 전문의 (SK)와 면허가 있는 임상 사회 복지사(HB)로 구성되었다. 소아 뇌전증 전문의의 역할은 환자와 가족에게 PNES 진단을 확인, 설명 및 전달하는 것이었다. 사회 복지사는 인터뷰와 설문지를 통해 심리적 위험 요소를 광범위하게 선별하고, 마음챙김 및 인지 행동 치료와 같은 행동 건강 관리와의 연결을 장려하고, 적절한 의뢰를 하고, 치료의 장벽에 직면한 가족에게 지원을 제공했다.We retrospectively reviewed the medical charts of consecutive patients evaluated at the PNES Clinic at Children's Healthcare of Atlanta (CHOA) from July 2019 to March 2020. The PNES Clinic is located within the Department of Pediatric Neurology, Department of Pediatrics, Emory University CHOA. CHOA's PNES Clinic focuses on transitioning patients with PNES from evaluation to treatment. Typical referral sources included neurologists, emergency medical practitioners, in-hospital consultations including EEG monitoring devices, and primary care providers. The clinic team consisted of a pediatric epilepsy specialist (SK) and a licensed clinical social worker (HB). The role of the pediatric epilepsy specialist was to confirm, explain, and communicate the diagnosis of PNES to patients and families. Social workers broadly screen for psychological risk factors through interviews and questionnaires, encourage connections to behavioral health care such as mindfulness and cognitive behavioral therapy, make appropriate referrals, and provide support to families facing barriers to care. provided.
소아 뇌전증 전문의는 2013년 ILAE(International League against Epilepsy) 비 뇌전증 발작 태스크포스에서 제안한 임상 병력, 목격된 사건 및 뇌파도(EEG) 소견을 기반으로 PNES를 진단했다. 태스크포스는 PNES에 대해 다음과 같은 진단 수준을 제안했다: (1) 환자 또는 목격자의 임상 병력 및 정상적인 발작 간 EEG에 의해 결정된 가능한 PNES; (2) 임상 병력, 직접 목격한 임상의 또는 사건의 비디오 녹화 검토 및 정상적인 발작 간 EEG에 의해 결정된 예상 PNES; (3) 임상 병력, 임상의 증인, 비디오 없이 습관적인 사건의 외래 EEG 기록에 의해 결정된 임상적으로 확립된 PNES, 및 (4) 임상 병력과 습관적인 사건의 비디오-EEG 기록으로 결정된 문서화된 PNES.A pediatric epilepsy specialist diagnosed PNES based on clinical history, witnessed events, and electroencephalogram (EEG) findings as suggested by the 2013 International League against Epilepsy (ILAE) Non-Epileptic Seizures Task Force. The task force proposed the following diagnostic levels for PNES: (1) probable PNES as determined by the patient's or witness' clinical history and normal interictal EEG; (2) expected PNES as determined by clinical history, review of a directly witnessed clinician or video recording of the event, and normal interictal EEG; (3) clinically established PNES, as determined by clinical history, clinician witness, and outpatient EEG recording of habitual events without video, and (4) documented PNES as determined by clinical history and video-EEG recording of habitual events.
다양한 진단 수준의 PNES 확실성을 가진 어린이가 본 연구에 포함되었다. 비뇌전증 사건이 포착되고 EEG의 확인을 받았다면 뇌전증 진단을 동시에 받은 환자를 포함하였다(n=8). 동반이환 뇌전증은, 상응하는 발작 또는 뇌전증 사이의 뇌전증양 방전에 의해 확인하여, PNES 증상과 구별되는 뇌전증 증후학으로 정의되었다. 9개월의 연구 기간 동안 65명의 환자가 예정되어 있었고 51명의 어린이가 PNES 클리닉에 와서 평가를 받았다. 2명의 환자를 제외하고 49명의 환자가 본 연구에 등록되었다; 한 환자는 PNES가 없었지만 다른 운동 증상이 있었고 다른 환자는 뇌전증 발작과 뇌전증 진단만 있었다. Children with varying levels of diagnostic certainty of PNES were included in this study. Patients with a concurrent diagnosis of epilepsy were included if a non-epileptic event was captured and confirmed by EEG (n=8). Comorbid epilepsy was defined as epilepsy symptomatology distinct from PNES symptoms, as confirmed by epileptiform discharges between corresponding seizures or epilepsies. During the 9-month study period, 65 patients were scheduled and 51 children presented to the PNES clinic for evaluation. Excluding two patients, 49 patients were enrolled in this study; One patient did not have PNES but had other motor symptoms, and the other patient had only epileptic seizures and a diagnosis of epilepsy.
환자 설문지를 사용하여 인구 통계(연령, 성별, 인종) 및 임상 변수를 수집했다. 임상 변수에는 PNES 발병 연령, 발작 빈도, 지난해 응급실 방문 빈도, 정신과 진단 및 약물 치료 이력, 심각한 자살 충동 또는 시도, 동시 뇌전증 또는 뇌전증 병력, 학습장애, 발작 또는 정신 장애의 가족력, 사회적 환경(가족 기능 장애 및 학교 문제) 및 트라우마 병력(성적 학대 및 비성적 학대)이 포함되었다. 비성적 학대에는 신체적 학대, 정서적 학대, 가족이나 집에서 폭력을 목격하거나 경험하는 것이 포함된다. 가족 기능 장애에는 이혼 또는 별거, 편부모, 심각한 가족 분쟁이 포함되었다. 심리사회적 기능 및 신체 증상도 소아 증상 체크리스트-17(PSC-17) 및 소아 신체 증상 목록-8(CSSI-8)을 사용하여 일상적으로 평가했다.Demographics (age, gender, race) and clinical variables were collected using patient questionnaires. Clinical variables included age at onset of PNES, frequency of seizures, frequency of emergency department visits in the past year, history of psychiatric diagnosis and medication, severe suicidal thoughts or attempts, concurrent epilepsy or history of epilepsy, learning disability, family history of seizures or mental disorders, and social environment (family). dysfunction and school problems) and history of trauma (sexual and non-sexual abuse). Non-sexual abuse includes physical abuse, emotional abuse, and witnessing or experiencing violence in the family or home. Family dysfunction included divorce or separation, single parenthood, and severe family conflict. Psychosocial functioning and somatic symptoms were also routinely assessed using the Pediatric Symptom Checklist-17 (PSC-17) and Pediatric Somatic Symptom Inventory-8 (CSSI-8).
PSC-17은 4~18세 소아 환자의 심리사회적 문제를 평가하기 위해 부모가 작성한 측정 결과로 개발된 17개 항목의 설문지이다. 완성된 PSC-17에서 총점, 외부화 하위 척도 점수, 내재화 하위 척도 점수, 주의 하위 척도 점수의 네 가지 점수를 도출할 수 있다. 총점의 범위는 0에서 34까지이며 아동의 전반적인 심리사회적 기능을 평가하도록 설계되었다. 점수가 높을수록 위험이 더 큰 것으로 나타났다. 총 점수에서 _15의 검증된 컷오프 점수는 전반적인 정신 건강 위험을 나타낸다. 점수 _7은 주의 및 외부화 하위 척도 모두에 대한 위험을 나타내고 점수 _5는 내재화 하위 척도에 대한 위험을 나타낸다. 긍정적인 점수는 특정한 근본적인 정신 건강 문제의 위험과 관련이 있다. 내재화 항목은 우울증 및 불안의 위험, 주의력 결핍 과잉 행동 장애(ADHD)에 대한 주의 항목, 행동 또는 반항 장애에 대한 외현화 항목과 관련된다. 소아 증상 체크리스트-17은 신뢰도(내적 일관성 0.87-0.89; 테스트-재테스트 0.85-0.89) 및 타당성에 대해 철저하게 조사되었다.The PSC-17 is a 17-item questionnaire developed from measures completed by parents to assess psychosocial problems in pediatric patients aged 4 to 18 years. Four scores can be derived from the completed PSC-17: total score, externalizing subscale score, internalizing subscale score, and attention subscale score. The total score ranges from 0 to 34 and is designed to assess the child's overall psychosocial functioning. The higher the score, the greater the risk. A validated cutoff score of _15 on the total score indicates overall mental health risk. A score of _7 indicates risk for both the Attention and Externalizing subscales and a score of _5 indicates risk for the Internalizing subscale. Positive scores are associated with the risk of certain underlying mental health problems. Internalizing items are associated with risk for depression and anxiety, attention items for attention deficit hyperactivity disorder (ADHD), and externalizing items for conduct or oppositional defiant disorder. The Pediatric Symptom Checklist-17 has been thoroughly examined for reliability (internal consistency 0.87-0.89; test-retest 0.85-0.89) and validity.
CSSI-8은 8~17세 아동 및 청소년의 지난 2주간의 신체적 증상을 평가하기 위한 8개 항목 설문지이다. 이러한 항목은 검증된 24개 항목의 아동 신체화 검사 항목에서 도출되었으며 간단한 측정이 필요할 때 사용되었다. 복통, 머리, 허리, 팔/다리, 실신/어지러움, 빠른 심장 박동, 메스꺼움/위 문제 및 쇠약을 다루었다. 각 항목은 1(신경쓰지 않음)에서 4(매우 신경쓰임)까지 점수를 매기고 평균 점수를 계산했다. 성가신 증상은 3점 이상의 단일 항목으로 정의하였다. Cronbach's alpha는 이전 연구에서 0.75-0.77 범위로 수용 가능했다. 모든 절차는 CHOA 기관 검토 위원회(IRB)의 승인을 받았다.The CSSI-8 is an 8-item questionnaire to assess physical symptoms over the past 2 weeks in children and adolescents aged 8 to 17 years. These items were derived from the validated 24-item Children's Somatization Test and were used when a simple measurement was needed. Addressed abdominal pain, head, back, arms/legs, fainting/dizziness, fast heartbeat, nausea/stomach issues and weakness. Each item was scored from 1 (not concerned) to 4 (very concerned), and the average score was calculated. Troublesome symptoms were defined as a single item with a score of 3 or higher. Cronbach's alpha was acceptable in the range of 0.75-0.77 in previous studies. All procedures were approved by the CHOA Institutional Review Board (IRB).
2. 통계 분석 방법2. Statistical analysis method
범주형 변수에 대한 빈도 및 백분율(%)과 연속 변수에 대한 중앙값(최소-최대)이 보고되었다. 적용 가능한 경우 범주형 변수 간의 연관성을 평가하기 위해 Fisher의 정확 테스트를 사용했다. Mann-Whitney U 테스트는 연속 변수를 비교하는 데 사용되었다. 데이터는 SPSS 버전 21(IBM SPSS Inc., Chicago, IL, USA)을 사용하여 분석되었다. 양측 p 값 <0.05는 통계적으로 유의한 것으로 간주되었다.Frequencies and percentages (%) for categorical variables and medians (min-max) for continuous variables were reported. Fisher's exact test was used to assess associations between categorical variables when applicable. The Mann-Whitney U test was used to compare continuous variables. Data were analyzed using SPSS version 21 (IBM SPSS Inc., Chicago, IL, USA). A two-sided p value <0.05 was considered statistically significant.
3. 대상3. Target
가장 흔한 의뢰 과정은 신경과 전문의( n = 19, 39%), 응급 의료 제공자( n = 13, 27%), 병원 내 상담( n = 11, 22%), 1차 진료의( n = 6, 12%)였다. EEG는 모든 환자에게 수행되었다: 31명의 환자에서 장기 비디오-EEG 모니터링, 40명의 환자에서 일상적인 EEG, 그리고 25명의 환자에서 모두 EEG를 수행했다. 가장 일반적인 진단 확실성 수준은 기록된 PNES( n = 29, 60%)이고 나머지는 PNES 가능성( n = 20, 40%)이었다. 대부분의 환자( n = 38, 78%)는 여성이었고 나머지 11명(22%)은 남성이었다. 대부분의 환자는 아프리카계 미국인( n = 32, 65%)이었고 16명(33%)은 백인이었다. PNES 증상이 시작된 평균 연령은 14.0(7-18)세였으며, 처음 병원을 방문했을 때의 중앙 연령은 클리닉은 15.0(9-19)년이었다. PNES 기간 중앙값은 1.0(0.1-9.0)년이었다. 절반 이상의 환자( n = 29, 59%)가 PNES를 매일 또는 매주 경험했다. 뇌전증의 동시 또는 과거력은 8명의 환자(16%)에서 발견되었다. 학습장애는 17명의 환자(37%)에서 보고되었다. 코호트의 인구학적 특성은 표 1 에 요약되어 있다.The most common referral processes were neurologists ( n = 19, 39%), emergency medical providers ( n = 13, 27%), in-hospital consultations ( n = 11, 22%), and primary care physicians ( n = 6 , 12%). EEG was performed in all patients: long-term video-EEG monitoring in 31 patients, routine EEG in 40 patients, and full EEG in 25 patients. The most common level of diagnostic certainty was documented PNES ( n = 29, 60%), with the remainder being probable PNES ( n = 20, 40%). Most patients ( n = 38, 78%) were female and the remaining 11 (22%) were male. Most patients were African American ( n = 32, 65%) and 16 (33%) were white. The median age at onset of PNES symptoms was 14.0 (7-18) years, and the median age at first clinic visit was 15.0 (9-19) years. Median PNES duration was 1.0 (0.1-9.0) years. More than half of patients ( n = 29, 59%) experienced PNES daily or weekly. Concurrent or previous history of epilepsy was found in 8 patients (16%). Learning disabilities were reported in 17 patients (37%). The demographic characteristics of the cohort are summarized in Table 1.
[표 1][Table 1]
a 가족 기능 장애: 이혼 또는 별거, 편부모, 심각한 가족 분쟁, 불안정한 주택.a Family dysfunction: divorce or separation, single parenthood, serious family conflict, unstable housing.
b 신체적 학대, 정서적 학대, 가족이나 가정에서 폭력을 목격하거나 경험하는 것, 지역사회에서 폭력을 목격하거나 경험하는 것, 사랑하는 사람의 갑작스럽거나 폭력적인 죽음, 심각한 사고 또는 생명을 위협하는 질병, 난민 및 전쟁 경험, 노숙자 또는 위탁 배려, 왕따. b Physical abuse, emotional abuse, witnessing or experiencing violence in the family or home, witnessing or experiencing violence in the community, sudden or violent death of a loved one, serious accident or life-threatening illness, refugee and War experiences, homelessness or foster care, bullying.
4. 성별에 따른 임상 변수의 단변량 분석4. Univariate analysis of clinical variables according to gender
표 2 는 성별에 따른 단변량 분석 결과를 보여준다. 여성은 전반적인 외상/학대(58% vs 9%, p = 0.01)와 자살 충동/시도(47% vs 1%, p = 0.03)가 더 많았지만 남성에 비해 학습장애는 적었다(26% vs 63%, p = 0.03). 인종, PNES 발병 연령, 진료소 방문 연령, PNES 기간, 작년 응급실 방문 빈도, 에피소드 빈도, PNES에 대한 항발작 약물의 병력, 과거 또는 현재 정신 건강 약물, 가족 기능 장애, 갈등을 포함한 기타 변수 교사나 동료, 발작이나 정신 질환의 가족력은 남녀 간에 차이가 없었다.Table 2 shows the results of univariate analysis by gender. Women had more overall trauma/abuse (58% vs 9%, p = 0.01) and suicidal thoughts/attempts (47% vs 1%, p = 0.03), but fewer learning difficulties than men (26% vs 63%). , p = 0.03). Other variables, including race, age at onset of PNES, age at clinic visit, duration of PNES, frequency of emergency room visits in the past year, frequency of episodes, history of antiseizure medication for PNES, past or current mental health medications, family dysfunction, conflict with teachers or peers; There was no difference in family history of seizures or mental illness between men and women.
[표 2][Table 2]
a 가족 기능 장애: 이혼 또는 별거, 편부모, 심각한 가족 분쟁, 불안정한 주택.a Family dysfunction: divorce or separation, single parenthood, serious family conflict, unstable housing.
b 신체적 학대, 정서적 학대, 가족이나 가정에서 폭력을 목격하거나 경험하는 것, 지역사회에서 폭력을 목격하거나 경험하는 것, 사랑하는 사람의 갑작스럽거나 폭력적인 죽음, 심각한 사고 또는 생명을 위협하는 질병, 난민 및 전쟁 경험, 노숙자 또는 위탁 배려, 왕따. b Physical abuse, emotional abuse, witnessing or experiencing violence in the family or home, witnessing or experiencing violence in the community, sudden or violent death of a loved one, serious accident or life-threatening illness, refugee and War experiences, homelessness or foster care, bullying.
* p < 0.05.*p < 0.05.
5. 심리사회적 기능5. Psychosocial functioning
소아 증상 체크리스트-17은 45명의 환자에서 확인되었다. 그 중 24명(53%)은 심각한 행동 또는 정서적 문제가 있었다. 컷오프 이상의 점수를 받은 환자는 내면화 하위 척도에서 가장 빈번했다( n = 21, 47%). 소수의 환자( n = 2, 4%)는 외부화 하위 척도 내에서 위험을 보였다(도 1). PSC-17 분석에서는 성별에 따른 차이가 없었다. CSSI-8은 48명의 환자에서 확인되었다. 두통이 가장 흔한 성가신 신체 증상( n = 20, 42%)이었고, 사지 통증( n = 13, 27%)과 현기증( n = 13, 27%) 이 그 뒤를 이었다 (도 2). 성가신 신체적 증상호소는 여성과 남성 간에 차이가 없었다. Pediatric Symptom Checklist-17 was confirmed in 45 patients. Of these, 24 (53%) had serious behavioral or emotional problems. Patients scoring above the cutoff were most frequent on the internalizing subscale ( n = 21, 47%). A small number of patients ( n = 2, 4%) showed risk within the externalizing subscale ( Fig. 1 ). There was no difference by gender in the PSC-17 analysis. CSSI-8 was identified in 48 patients. Headache was the most common bothersome physical symptom ( n = 20, 42%), followed by limb pain ( n = 13, 27%) and dizziness ( n = 13, 27%) (Figure 2). There was no difference in bothersome physical symptoms between women and men.
Claims (2)
- 소아 심인성비뇌전증발작 환자가 여아인 경우 남아인 경우보다 트라우마로 인한 것일 확률이 높을 것이며, 남아인 경우 여아인 경우보다 학습장애로 인한 것일 확률이 높을 것이라는 정보를 제공하는 단계;를 포함하는, 소아 심인성비뇌전증발작 환자의 병인 진단을 위한 정보제공방법.If the pediatric psychogenic non-epileptic seizure patient is a girl, there will be a higher probability that it is caused by trauma than if the patient is a boy, and if the patient is a boy, the probability that it is caused by a learning disability will be higher than if the patient is a girl; including; Information provision method for etiological diagnosis in pediatric patients with psychogenic non-epileptic seizures.
- 청구항 1에 있어서, 상기 트라우마는 성적 학대로 인한 것인 소아 심인성비뇌전증발작 환자의 병인 진단을 위한 정보제공방법.The method of claim 1, wherein the trauma is caused by sexual abuse.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2022/020952 WO2024135881A1 (en) | 2022-12-21 | 2022-12-21 | Information provision method for diagnosing etiology of psychogenic non-epileptic seizures |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2022/020952 WO2024135881A1 (en) | 2022-12-21 | 2022-12-21 | Information provision method for diagnosing etiology of psychogenic non-epileptic seizures |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024135881A1 true WO2024135881A1 (en) | 2024-06-27 |
Family
ID=91589086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2022/020952 WO2024135881A1 (en) | 2022-12-21 | 2022-12-21 | Information provision method for diagnosing etiology of psychogenic non-epileptic seizures |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024135881A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020516407A (en) * | 2017-04-13 | 2020-06-11 | ブレイン センティネル インコーポレイテッドBrain Sentinel,Inc. | Method and apparatus for monitoring seizures |
KR20200080621A (en) * | 2018-12-27 | 2020-07-07 | 서울대학교병원 | System for managing information related to epilepsy |
KR20220082285A (en) * | 2020-12-10 | 2022-06-17 | 주식회사 브레인유 | Method for providing information of epilepsy and device using the same |
-
2022
- 2022-12-21 WO PCT/KR2022/020952 patent/WO2024135881A1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020516407A (en) * | 2017-04-13 | 2020-06-11 | ブレイン センティネル インコーポレイテッドBrain Sentinel,Inc. | Method and apparatus for monitoring seizures |
KR20200080621A (en) * | 2018-12-27 | 2020-07-07 | 서울대학교병원 | System for managing information related to epilepsy |
KR20220082285A (en) * | 2020-12-10 | 2022-06-17 | 주식회사 브레인유 | Method for providing information of epilepsy and device using the same |
Non-Patent Citations (2)
Title |
---|
JANG MI-NA, KIM HEESOON: "An Analysis of Factors Influencing Parenting Stress in Children with Epilepsy", CHILD HEALTH NURSING RESEARCH, vol. 22, no. 3, 31 July 2016 (2016-07-31), pages 163 - 171, XP093183682, ISSN: 2287-9110, DOI: 10.4094/chnr.2016.22.3.163 * |
LEE JEE YEON, LEE HEE SUN, CHOI WOOK SUN, EUN SO HEE, LEE KI HYUNG, EUN BAIK LIN, LEE JOO WON: "Usefulness of video-EEG monitoring in paroxysmal nonepileptic events of children and adolescents", KOREAN JOURNAL OF PEDIATRICS, vol. 51, no. 1, 1 January 2008 (2008-01-01), pages 62, XP093183680, ISSN: 1738-1061, DOI: 10.3345/kjp.2008.51.1.62 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bodde et al. | Psychogenic non-epileptic seizures—definition, etiology, treatment and prognostic issues: a critical review | |
Nightingale et al. | The association between narcolepsy and REM behavior disorder (RBD) | |
Prosad Paul et al. | Clinical update: febrile convulsion in childhood. | |
Elmali et al. | How to diagnose and classify idiopathic (genetic) generalized epilepsies | |
Frazier et al. | Possible selves and illness: A comparison of individuals with Parkinson's disease, early-stage Alzheimer's disease, and healthy older adults | |
VanderPlate | Psychological aspects of multiple sclerosis and its treatment: Toward a biopsychosocial perspective. | |
Chabolla et al. | Psychogenic nonepileptic seizures | |
Thompson et al. | Nonepileptic seizures: reframing the diagnosis | |
Van Hoof et al. | Defining the occurrence and influence of alpha-delta sleep in chronic fatigue syndrome | |
WO2024135881A1 (en) | Information provision method for diagnosing etiology of psychogenic non-epileptic seizures | |
Moattari et al. | The prevalence of cognitive impairment in Patients with Type II Diabetes and its Relationship with Quality of Life, Self-Management Profiles, and HbA1c | |
Martin et al. | Cognition and the body: Somatic attributions in irritable bowel syndrome | |
Agarwal et al. | Psychogenic non-epileptic seizures in children | |
Towbin | Autism and Asperger's syndrome | |
Kuester et al. | Attentional bias in German Armed Forces veterans with and without posttraumatic stress symptoms–An eye-tracking investigation and group comparison | |
Singh et al. | Deciphering the Puzzle: Exploring the Etiology of Psychogenic Non-Epileptic Seizures | |
Marti et al. | The role of the epilepsy monitoring unit in the investigation of patients with epilepsy and intellectual disabilities | |
Quinton | The processing of threat‐related information in female dieters and non‐dieters | |
Halper et al. | An overview of multiple sclerosis | |
Wang et al. | Clinical manifestations of psychogenic non-epileptic seizures in children: Experiences from a single center | |
Bullock et al. | Psychiatric factors | |
Funata et al. | Respiratory arrest at the onset of idiopathic childhood occipital epilepsy of Gastaut | |
Osváth et al. | Risk factors and personality characteristics of nonsuicidal self-injurious behavior in clinical sample of female adolescents | |
Gross et al. | Functional convulsions masked as epileptic disorders | |
Pop-Jordanova et al. | Electrodermal biofeedback in treating psychogenic nonepileptic seizures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22969315 Country of ref document: EP Kind code of ref document: A1 |